Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nature ; 563(7730): 275-279, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30401839

RESUMEN

The serotonin 5-HT3 receptor is a pentameric ligand-gated ion channel (pLGIC). It belongs to a large family of receptors that function as allosteric signal transducers across the plasma membrane1,2; upon binding of neurotransmitter molecules to extracellular sites, the receptors undergo complex conformational transitions that result in transient opening of a pore permeable to ions. 5-HT3 receptors are therapeutic targets for emesis and nausea, irritable bowel syndrome and depression3. In spite of several reported pLGIC structures4-8, no clear unifying view has emerged on the conformational transitions involved in channel gating. Here we report four cryo-electron microscopy structures of the full-length mouse 5-HT3 receptor in complex with the anti-emetic drug tropisetron, with serotonin, and with serotonin and a positive allosteric modulator, at resolutions ranging from 3.2 Å to 4.5 Å. The tropisetron-bound structure resembles those obtained with an inhibitory nanobody5 or without ligand9. The other structures include an 'open' state and two ligand-bound states. We present computational insights into the dynamics of the structures, their pore hydration and free-energy profiles, and characterize movements at the gate level and cation accessibility in the pore. Together, these data deepen our understanding of the gating mechanism of pLGICs and capture ligand binding in unprecedented detail.


Asunto(s)
Microscopía por Crioelectrón , Receptores de Serotonina 5-HT3/química , Receptores de Serotonina 5-HT3/ultraestructura , Regulación Alostérica/efectos de los fármacos , Animales , Sitios de Unión , Activación del Canal Iónico , Ligandos , Ratones , Simulación de Dinámica Molecular , Movimiento/efectos de los fármacos , Conformación Proteica/efectos de los fármacos , Receptores de Serotonina 5-HT3/metabolismo , Serotonina/química , Serotonina/metabolismo , Antagonistas del Receptor de Serotonina 5-HT3/farmacología , Anticuerpos de Dominio Único/farmacología , Termodinámica , Tropisetrón/química , Tropisetrón/metabolismo , Tropisetrón/farmacología
2.
J Biol Chem ; 292(7): 2703-2713, 2017 02 17.
Artículo en Inglés | MEDLINE | ID: mdl-28069810

RESUMEN

Rhomboid proteases are increasingly being explored as potential drug targets, but their potent and specific inhibitors are not available, and strategies for inhibitor development are hampered by the lack of widely usable and easily modifiable in vitro activity assays. Here we address this bottleneck and report on the development of new fluorogenic transmembrane peptide substrates, which are cleaved by several unrelated rhomboid proteases, can be used both in detergent micelles and in liposomes, and contain red-shifted fluorophores that are suitable for high-throughput screening of compound libraries. We show that nearly the entire transmembrane domain of the substrate is important for efficient cleavage, implying that it extensively interacts with the enzyme. Importantly, we demonstrate that in the detergent micelle system, commonly used for the enzymatic analyses of intramembrane proteolysis, the cleavage rate strongly depends on detergent concentration, because the reaction proceeds only in the micelles. Furthermore, we show that the catalytic efficiency and selectivity toward a rhomboid substrate can be dramatically improved by targeted modification of the sequence of its P5 to P1 region. The fluorogenic substrates that we describe and their sequence variants should find wide use in the detection of activity and development of inhibitors of rhomboid proteases.


Asunto(s)
Colorantes Fluorescentes/química , Péptido Hidrolasas/metabolismo , Péptidos/metabolismo , Transferencia Resonante de Energía de Fluorescencia , Cinética , Liposomas , Especificidad por Sustrato
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA